Journal article · 2022 · Open access

A KCNC1‐related neurological disorder due to gain of Kv3.1 function

Jérôme Clatot, Natalie Ginn, Gregory Costain, Ethan M. Goldberg

Annals of Clinical and Translational Neurology, 10(1), 111–117 · Published 23 November 2022 · DOI 10.1002/acn3.51707

Open PDFView at the publisherCite this paper

In brief

“A KCNC1‐related neurological disorder due to gain of Kv3.1 function” is a 2022 journal article by Jérôme Clatot and 3 co-authors, published in Annals of Clinical and Translational Neurology. OpenAlex counts 51 citations as of 18 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Annals of Clinical and Translational Neurology.

Citations
51
Most cited in
2024 (35)
Field-weighted impact
3.04
References
19
Authors
4

Abstract

OBJECTIVE: To further clarify genotype:phenotype correlations associated with variants in KCNC1 encoding the voltage-gated potassium (K+) channel subunit Kv3.1 and which are an emerging cause of a spectrum of neurological disease including intellectual disability, isolated myoclonus, progressive myoclonus epilepsy, and developmental and epileptic encephalopathy. METHODS: We describe the clinical and genetic characteristics of a series of three patients with de novo heterozygous missense variants in KCNC1 associated with nonspecific developmental delay/intellectual disability and central hypotonia without epilepsy or ataxia. All three variants lead to amino acids alterations with mild predicted differences in physicochemical properties yet are localized to the S6 pore region of the Kv3.1 protein between the selectivity filter and PXP motif important for K+ channel gating. We performed whole-cell voltage clamp electrophysiological recording of wild-type versus variants in a heterologous mammalian expression system. RESULTS: We demonstrate a prominent leftward (hyperpolarized) shift in the voltage dependence of activation and slowed deactivation of all variants in the clinically defined series. INTERPRETATION: Electrophysiological recordings are consistent with a gain of K+ channel function that is predicted to exert a loss of function on the excitability of Kv3-expressing high frequency- firing neurons based on the unique electrophysiological properties of Kv3 channels. These results define a clinical-genetic syndrome within the spectrum of KCNC1-related neurological disorders.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Clatot, J., Ginn, N., Costain, G., & Goldberg, E. M. (2022). A KCNC1‐related neurological disorder due to gain of Kv3.1 function. Annals of Clinical and Translational Neurology, 10(1), 111–117. https://doi.org/10.1002/acn3.51707

MLA 9

Clatot, Jérôme, et al. “A KCNC1‐related neurological disorder due to gain of Kv3.1 function.” Annals of Clinical and Translational Neurology, vol. 10, no. 1, 2022, pp. 111–117. https://doi.org/10.1002/acn3.51707.

Chicago

Clatot, Jérôme, Natalie Ginn, Gregory Costain, and Ethan M. Goldberg. 2022. “A KCNC1‐related neurological disorder due to gain of Kv3.1 function.” Annals of Clinical and Translational Neurology 10 (1): 111–117. https://doi.org/10.1002/acn3.51707.

Harvard

Clatot, J. et al. (2022) ‘A KCNC1‐related neurological disorder due to gain of Kv3.1 function’, Annals of Clinical and Translational Neurology, 10(1), pp. 111–117. doi:10.1002/acn3.51707.

IEEE

J. Clatot, N. Ginn, G. Costain, and E. M. Goldberg, “A KCNC1‐related neurological disorder due to gain of Kv3.1 function,” Annals of Clinical and Translational Neurology, vol. 10, no. 1, pp. 111–117, 2022, doi: 10.1002/acn3.51707.

BibTeX

@article{clatot2022kcnc,
  title     = {{A KCNC1‐related neurological disorder due to gain of Kv3.1 function}},
  author    = {Clatot, Jérôme and Ginn, Natalie and Costain, Gregory and Goldberg, Ethan M.},
  journal   = {Annals of Clinical and Translational Neurology},
  year      = {2022},
  volume    = {10},
  number    = {1},
  pages     = {111--117},
  doi       = {10.1002/acn3.51707},
  url       = {https://doi.org/10.1002/acn3.51707}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202311
20243535
202588
202677

Its field-weighted citation impact is 3.04: it has been cited 3.04 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function

  • KCNC1
  • Kv3.1 potassium channel
  • gain-of-function
  • missense mutations
  • intellectual disability
  • developmental delay
  • central hypotonia
  • voltage dependence of activation

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Clatot, J., Ginn, N., Costain, G., & Goldberg, E. M. (2022). A KCNC1‐related neurological disorder due to gain of Kv3.1 function. Annals of Clinical and Translational Neurology, 10(1), 111–117. https://doi.org/10.1002/acn3.51707

How many times has this paper been cited?

51 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Annals of Clinical and Translational Neurology: sign in and open the PDF from this page.

Who wrote this paper?

Jérôme Clatot, Natalie Ginn, Gregory Costain, Ethan M. Goldberg.

What is the DOI of this paper?

10.1002/acn3.51707, permanently at https://doi.org/10.1002/acn3.51707. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.